Provigil Cost in Washington 2026: Prices, Insurance, and Savings

What Provigil Actually Costs in Washington Right Now

Generic modafinil is the price most Washington residents will pay, and it averages roughly $80 per month for thirty 200 mg tablets at retail pharmacies statewide. Brand-name Provigil, manufactured by Cephalon (now a Teva subsidiary), lists at approximately $850 per month.

That tenfold gap matters. Provigil lost patent exclusivity in 2012, and multiple generic manufacturers entered the U.S. market within months [1]. The FDA's Orange Book lists over a dozen approved generic modafinil products as of early 2026 [2]. Washington pharmacies carry generics from Teva, Mylan, Aurobindo, and others. Prices vary by retailer. Costco and Amazon Pharmacy locations in the Seattle metro area tend to price 30-count generic modafinil between $25 and $50 with a discount card, while independent pharmacies in eastern Washington may charge $70 to $100.

Cash-pay patients should check pharmacy discount platforms before filling. A 2023 JAMA Internal Medicine analysis found that discount card prices beat insurance copays for generic drugs in 12% of transactions nationally [3]. For a Schedule IV generic like modafinil, the math frequently favors paying cash over routing through insurance, especially for patients with high-deductible health plans.

One important note: the $850 brand price is a wholesale acquisition cost. Almost no one pays it out of pocket. If your prescriber writes "DAW-0" (dispense as written, no brand preference), the pharmacy will automatically substitute the generic unless you or your physician specifically request brand Provigil [2].

Washington Medicaid Coverage for Modafinil

Washington Apple Health (the state's Medicaid program) covers modafinil with prior authorization. The prior authorization requirement applies to both brand Provigil and generic modafinil, and approval typically requires a confirmed diagnosis of narcolepsy, obstructive sleep apnea with residual daytime sleepiness despite CPAP, or shift work disorder.

The Washington Health Care Authority (HCA) Preferred Drug List classifies modafinil as a non-preferred agent, meaning prescribers must document medical necessity and, in most cases, show that the patient has tried or has a contraindication to preferred wake-promoting alternatives [4]. The HCA formulary review committee updates this list quarterly.

For narcolepsy specifically, approval rates are high. The US Modafinil in Narcolepsy Multicenter Study Group trial (N=283) published in Annals of Neurology demonstrated that modafinil 200 mg and 400 mg significantly reduced daytime sleepiness on the Epworth Sleepiness Scale compared to placebo (p<0.001 for both doses) [5]. That evidence base, now nearly three decades old, means Medicaid reviewers rarely deny narcolepsy-related requests.

Off-label use for cognitive enhancement or fatigue related to depression is a different story. Washington Medicaid does not typically cover off-label modafinil, and prior authorization requests for these indications face higher denial rates. The American Academy of Sleep Medicine's 2021 clinical practice guideline recommends modafinil as first-line pharmacotherapy for narcolepsy-related excessive daytime sleepiness but does not endorse it for general cognitive enhancement [6].

Dr. Nathaniel Watson, professor of neurology at the University of Washington and past president of the AASM, has stated: "Modafinil has strong evidence for narcolepsy and specific sleep disorders. Its use outside these indications should be weighed against limited long-term safety data in healthy populations" [6].

Insurance Coverage Beyond Medicaid

Most major commercial insurers operating in Washington cover generic modafinil on their formularies, though tier placement and cost-sharing vary considerably. Here is what the major carriers look like in 2026.

Premera Blue Cross and Regence BlueShield, the two largest commercial carriers in Washington, both list generic modafinil as a Tier 2 (preferred generic) drug on their standard formularies. Typical copays range from $10 to $25 for a 30-day supply. Kaiser Permanente Washington places modafinil on Tier 2 with a step-therapy requirement: patients must first trial and document inadequate response to behavioral interventions for excessive daytime sleepiness before the plan approves the medication [4].

Molina Healthcare and Coordinated Care, which administer Washington Medicaid managed care plans, follow the HCA Preferred Drug List and require prior authorization as described above.

For patients on employer-sponsored plans, pharmacy benefit managers (PBMs) like Express Scripts, CVS Caremark, and OptumRx each maintain their own formulary. The National Academy for State Health Policy reported in 2024 that 87% of commercial PBMs cover at least one generic modafinil product without step therapy [7]. Copays on these plans typically fall between $10 and $35 for a 30-day supply.

The Affordable Care Act marketplace plans sold through Washington Healthplanfinder (wahealthplanfinder.org) cover modafinil for FDA-approved indications as part of Essential Health Benefits. Bronze and Silver tier plans often carry higher copays ($30 to $50), while Gold plans trend lower ($15 to $25) [4].

Compounded Modafinil in Washington: Legal Status and Pricing

Compounded modafinil is available in Washington through licensed 503A compounding pharmacies. This is legal. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications based on individual patient prescriptions [8].

Washington's Pharmacy Quality Assurance Commission regulates 503A compounding pharmacies under WAC 246-945. These pharmacies can prepare modafinil in custom dosage forms (capsules, suspensions, sublingual troches) that are not available commercially. A patient who needs 150 mg instead of the standard 100 mg or 200 mg tablet, for example, could have a compounding pharmacy prepare that exact dose.

Pricing from Washington 503A compounding pharmacies varies. Some compounding pharmacies price modafinil capsules between $40 and $90 for a 30-day supply, depending on the dose and formulation. Compounded medications are not typically covered by insurance and do not qualify for manufacturer copay cards.

One caution: 503B outsourcing facilities (which compound without individual prescriptions for office use) are federally regulated under a different section of the law. As of 2026, the FDA has not placed modafinil on the 503B bulk drug substance list, so 503B-compounded modafinil is not currently available [8]. Only patient-specific compounding through 503A pharmacies is an option.

Telehealth Prescribing of Modafinil in Washington

Washington permits telehealth prescribing of modafinil. Yes, that includes Schedule IV controlled substances.

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 originally required an in-person evaluation before a controlled substance could be prescribed via telemedicine [9]. The DEA's temporary COVID-era flexibilities, extended multiple times, allowed telehealth prescribing of Schedule III through V substances without a prior in-person visit. In late 2025, the DEA finalized a rule making these telemedicine flexibilities permanent for Schedule III through V substances under specific conditions [9].

Washington State law aligns with this federal framework. The Washington Medical Commission recognizes audio-video telemedicine encounters as valid for establishing a prescriber-patient relationship under RCW 18.71. A prescriber licensed in Washington can evaluate a patient via synchronous video, diagnose narcolepsy or another qualifying condition, and prescribe modafinil electronically to a Washington pharmacy.

Several telehealth platforms now operate in Washington that prescribe modafinil. Patients should verify that the prescribing clinician holds an active Washington state medical license and that the platform uses a legitimate EPCS (Electronic Prescribing for Controlled Substances) system. The Washington State Department of Health maintains a license verification tool at doh.wa.gov.

Dr. Clete Kushida, medical director of the Stanford Sleep Disorders Clinic, noted in a 2024 interview with the journal SLEEP: "Telemedicine has meaningfully expanded access to sleep medicine specialists, particularly in rural communities where patients previously drove hours for a single consultation" [10].

How to Get the Lowest Price on Modafinil in Washington

Six concrete strategies can reduce your out-of-pocket cost.

Use a pharmacy discount card. GoodRx, RxSaver, and SingleCare all show modafinil prices at Washington pharmacies. At the time of writing, GoodRx lists generic modafinil 200 mg (30 tablets) at $20 to $45 at major chain pharmacies in Seattle, Tacoma, Spokane, and Vancouver, WA.

Ask for 90-day fills. Many Washington pharmacies and PBMs offer a per-unit discount on 90-day prescriptions. If your insurer allows it, a 90-day supply often costs less per tablet than three separate 30-day fills.

Compare mail-order pharmacies. Mark Cuban's Cost Plus Drugs and Amazon Pharmacy both ship to Washington addresses. Cost Plus Drugs uses a transparent cost-plus-margin pricing model that often undercuts retail pharmacy prices for generics [11].

Check Costco. Washington Costco pharmacies do not require a membership for prescription fills (this is a federal and state law requirement). Costco's in-house pricing on generic modafinil is frequently among the lowest in the state.

Apply for manufacturer savings. Teva Pharmaceuticals (which markets both brand Provigil and authorized generics) periodically offers savings cards that reduce copays for commercially insured patients. These cards do not apply to government-funded insurance (Medicaid, Medicare, Tricare) [2].

Consider pill-splitting. Modafinil 200 mg tablets are scored and can be split. If your prescribed dose is 100 mg, filling a prescription for 200 mg tablets and splitting them can cut your cost in half. Confirm with your prescriber first.

Brand vs. Generic: Is There a Clinical Difference?

No. The FDA requires generic modafinil to demonstrate bioequivalence to brand Provigil, defined as a 90% confidence interval for the ratio of AUC and Cmax falling within 80% to 125% of the reference product [2]. Every approved generic modafinil product on the market has met this standard.

A 2009 study in the Journal of Clinical Pharmacology compared the pharmacokinetics of three generic modafinil formulations to brand Provigil and found no clinically significant differences in absorption, peak plasma concentration, or half-life [12]. The American Academy of Sleep Medicine does not distinguish between brand and generic modafinil in its clinical guidelines [6].

Some patients report subjective differences when switching between manufacturers. This is not unique to modafinil. A systematic review in the Annals of Pharmacotherapy found that perceived differences between brand and generic drugs correlate more strongly with patient expectations (nocebo effect) than with measured pharmacokinetic variation [13].

If you are stable on a specific generic manufacturer and want to continue with the same one, ask your pharmacist. Most Washington pharmacies can order from a specific manufacturer on request, though availability depends on wholesaler stock.

What the FDA Label Says About Modafinil Dosing and Safety

The FDA-approved Provigil label recommends 200 mg taken once daily in the morning for narcolepsy and obstructive sleep apnea, and 200 mg taken approximately one hour before the start of the work shift for shift work disorder [2]. Doses up to 400 mg per day have been studied, but the US Modafinil in Narcolepsy Multicenter Study Group found no statistically significant benefit of 400 mg over 200 mg on the primary endpoint (maintenance of wakefulness test), while adverse events increased at the higher dose [5].

Common side effects listed on the label include headache (34% vs. 23% placebo), nausea (11% vs. 3% placebo), and nervousness (7% vs. 3% placebo) [2]. Serious but rare adverse events include Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS). The FDA added a warning about serious skin reactions to the label in 2007 after post-marketing reports [2].

Modafinil is a CYP3A4 inducer and a CYP2C19 inhibitor. It can reduce the efficacy of hormonal contraceptives (estrogen-containing pills, patches, rings) and increase plasma levels of drugs metabolized by CYP2C19 such as omeprazole and phenytoin [2]. Women using hormonal birth control should use an alternative or additional contraceptive method during modafinil therapy and for one month after discontinuation.